• CareAlign

  Participated · Seed · Jul 2020

  CareAlign provides a HIPAA-compliant task management system designed for health care providers and led by CEO Subha Airan-Javia, MD. The platform was initially validated in acute care settings, where it reduced the amount of time clinicians spend in the EHR and improved patient outcomes. This year the company expanded into post-acute and outpatient care and has begun offering solutions to value-based care organizations to help manage patient transitions across care settings. Key features include an integrated, real-time progress note format, a common communication thread linking users who share patient caseloads, and the ability to create checklists during rounds to avoid errors. CareAlign raised additional financing and intends to use the funds to expand both its sales force and its technology offerings. The company is based in Philadelphia, PA. TrekIT Health provides a HIPAA-compliant, secure, real-time workspace that synthesizes information across EHRs and care teams to improve clinician workflows. Its platform has been integrated at major health systems across the United States. The product is in use by over 150 different clinical services and more than 5,000 users a month. The company is led by CEO Subha Airan-Javia, MD. TrekIT announced the appointment of Rick Valencia as executive chairman; Valencia previously led Qualcomm Life and oversaw healthcare-focused funds. The company recently closed additional seed financing to support its growth and deployments.

• Tissue Analytics

  Participated · Seed · May 2015

  Tissue Analytics develops an EMR module for chronic wound management that uses machine learning to speed clinical documentation workflows and improve the quality of data. The company was incorporated in 2014 by Kevin Keenahan and is based in Baltimore, MD, with a satellite office in Kansas City, MO. It has partnered with Epic, Cerner, Allscripts and athenaHealth to distribute its product. Tissue Analytics raised $5M in a Series A round to support growth. The company intends to use the funds to expand the sales team in its Kansas City office and to hire data analytics personnel in Baltimore. The financing is positioned to support commercialization and analytics capability building. Tissue Analytics builds a smartphone-based app that captures wound images and quantifies wound size and characteristics. The company operates in wound imaging and telehealth, focusing on chronic wounds—a traditionally underserved and archaic area of medicine. It says its goals include modernizing care, improving care coordination, and providing a more objective way to evaluate wounds. Kevin Keenahan (identified in the article as CEO and co-founder) has discussed the company’s mission in prior interviews. Financially, Tissue Analytics recently completed a financing reported as debt. The company raised $1.92M in debt from a group of undisclosed investors, according to an SEC filing and confirmation from the CEO. Tissue Analytics provides a smartphone app that lets nurses capture wound images and a web portal where specialist clinicians can remotely monitor and manage chronic wounds. The product measures surface area, contraction rates, length and width, segments tissues, and applies color correction and basic image processing today. The team says it is collecting data for future predictive analytics and diagnostic features, with the eventual goal of suggesting therapies and pursuing regulatory submissions. The founders spun the company out of the Center for Bioengineering Innovation & Design at Johns Hopkins University in spring 2014 and launched a limited beta at Johns Hopkins followed by a more open beta. Customer numbers are not being disclosed in the articles. The company intends to position its technology as a SaaS offering to healthcare and insurance companies and is studying economic impact with Penn Medicine to support that sales pitch.

No current team members are available.